MedPath

Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response

Completed
Conditions
Fertility Disorders
Interventions
Other: blood sample
Registration Number
NCT03007043
Lead Sponsor
Institut Universitari Dexeus
Brief Summary

To evaluate the difference in the prevalence of the main FSHR polymorphism (ASN680Ser), as well as other, less studied, gonadotropin polymorphisms between ovarian response groups, following ovarian stimulation

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
364
Inclusion Criteria
  1. Age between 18-38 years old
  2. BMI 18-28
  3. Antral follicle count (AFC) > 9 or Anti-mullerian hormone (AMH) >1.1 ng/ml
  4. 1st or 2nd ovarian stimulation cycle for IVF/ICSI
  5. Planned to undergo ovarian stimulation with 150IU of rFSH in a fixed GnRH antagonist protocol
Exclusion Criteria
  1. Antral follicle count (AFC) <9 and AMH<1.1 ng/ml
  2. PCOS patients according to the Rotterdam criteria
  3. Patients undergoing in vitro maturation (IVM)
  4. Untreated endocrine abnormalities

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Normal respondersblood sampleNormal response following IVF
Suboptimal respondersblood sampleSuboptimal response following IVF
Primary Outcome Measures
NameTimeMethod
prevalence of the main FSH receptor polymorphism12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Department of Obstetrics and Gynecology, University of Medicine and Pharmacy HCMC, Ho Chi Minh City, Vietnam and Research Center for Genetics and Reproductive Health (CGRH), School of Medicine, Vietnam National University HCMC

🇻🇳

Ho Chi Minh City, Vietnam

Dexeus Salud de la Mujer

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath